Pancreatic Cancer Research

ResearcherBinzhou Medical UniversityNo recent work listed

Chen Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6011-4067; OpenAlex author ID A5100659396. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers

Papers 6

  1. Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells. First author DOI 10.1016/j.bcp.2021.114813↗
  2. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Co-author DOI 10.1038/s41419-021-03996-y↗
  3. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer. Co-author DOI 10.2147/dddt.s261017↗
  4. Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma. First author DOI 10.21037/tcr.2018.12.20↗
  5. Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarc… Co-author DOI 10.1038/s41598-017-00859-5↗
  6. Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemother… Co-author DOI 10.18632/oncotarget.16980↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guanghai Dai · 2 shared papers, 2017–2019 · strength 0.20
  2. Yan Xia Shi · 2 shared papers, 2017 · strength 0.18
  3. Maolei Xu · 1 shared paper, 2021 · strength 0.14
  4. Ling Zhou · 1 shared paper, 2021 · strength 0.14
  5. Xiaorong Li · 1 shared paper, 2019 · strength 0.11
  6. Wanwan Li · 1 shared paper, 2019 · strength 0.11
  7. Yi Zhang · 1 shared paper, 2020 · strength 0.11
  8. Xing Huang · 1 shared paper, 2020 · strength 0.11
  9. Chao Wu · 1 shared paper, 2020 · strength 0.11
  10. Li Wang · 1 shared paper, 2020 · strength 0.11
  11. Bole Tian · 1 shared paper, 2020 · strength 0.11
  12. Yonglie Zhou · 1 shared paper, 2021 · strength 0.11
  13. Jing Du · 1 shared paper, 2021 · strength 0.11
  14. Chaoting Zhou · 1 shared paper, 2021 · strength 0.11
  15. Xiangmin Tong · 1 shared paper, 2021 · strength 0.11
  16. Ying Wang · 1 shared paper, 2021 · strength 0.11
  17. Guang Hai Dai · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.